It builds up behind the blocked receptors and causes an energy crash when caffeine wears off
Our updated model projects US$139 billion in global sales in 2030 across both diabetes (59% of sales) and obesity (41% of sales), based on uptake in approximately eight percent and two percent of each category, respectively
IV nutrient therapy is fast becoming the preferred method for ensuring youre getting adequate vitamins and minerals and at IV Boost, many of our vitamin drips contain B12, but we also offer aB12 vitamin shotwho want instant delivery of this powerhouse vitamin to exactly where it is needed
Assists in reducing hyperpigmentation and dark spots

Market Positioning: Immune support / antioxidant / daily wellness Typical Formulation Logic: Liposomal Vitamin C (Ascorbic Acid or Sodium Ascorbate) Phospholipid complex (sunflower lecithin preferred) Optional synergists: Bioflavonoids (Citrus extract) Rosehip extract Zinc gluconate (immune synergy) Market Positioning: Detox/respiratory support/liver health/cellular antioxidant precursor Typical Formulation Logic: N-Acetyl-L-Cysteine (NAC) Glutathione (GSH) precursor / intracellular cysteine donor Liposomal delivery system (phosphatidylcholine) Improves stability and cellular uptake Synergistic stabilizers: Vitamin C (glutathione recycling) Alpha Lipoic Acid (redox support) Selenium (enzyme cofactor support) Market Positioning: Heart health/energy/mitochondrial support Typical Formulation Logic: Coenzyme Q10 (prefer ubiquinol form for the premium tier) Liposomal phospholipid matrix Energy synergists: L-Carnitine PQQ (mitochondrial biogenesis support) Vitamin E (lipid antioxidant protection) Market Positioning: Inflammation support / joint health / recovery Typical Formulation Logic: Curcumin extract (95% curcuminoids or enhanced curcumin) Liposomal encapsulation system Absorption enhancers: Phospholipid complex Piperine (optional, depending on market) Ginger extract (anti-inflammatory synergy) Structure stays standardized for R&D consistency and regulatory traceability Content is customized to GSH stability science, delivery physics, and target-market positioning Liposomal glutathione OEM work is not put GSH in phospholipids. Commercial formulas are built on five concurrent decision layers

FDA Guidelines for GLP-1 Medications The FDA has clear criteria for prescribing GLP-1 medications for chronic weight management: a BMI of 30 or higher, or a BMI of 27 with at least one weight-related comorbidity